Lactulose is a synthetic disaccharide used as a laxative. It works by drawing water into the colon and softening stool for easier bowel movements. Lactulose is often prescribed to treat occasional constipation and help manage symptoms of hepatic encephalopathy. The global lactulose market is experiencing high demand due to increasing cases of constipation worldwide and growing preference for preventive healthcare.

The global lactulose Market is estimated to be valued at US$ 175.29 Mn in 2023 and is expected to exhibit a CAGR of 3.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The inclination towards preventive healthcare is presenting lucrative growth opportunities for lactulose market. Constipation is a common problem worldwide and regular intake of lactulose helps in maintaining bowel health. It is gaining recognition as a prebiotic that supports the growth of beneficial gut bacteria. The prebiotic properties of lactulose are encouraging consumers to opt for it routinely rather than just as medicine. Manufacturers are promoting the various health benefits of lactulose such as lowering risk of colon cancer. The trend of self-medication for minor digestive issues is expected to further propel the demand for lactulose supplements.

Porter's Analysis

Threat of new entrants: The lactulose market requires high capital investments for R&D and manufacturing facilities limiting threats from new entrants.

Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitute products but buyers prefer branded products for better quality.

Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of raw material sources and established supply chain relationships of key players.

Threat of new substitutes: Threat from new substitutes is moderate as lactulose offers unique beneficial properties for constipation and liver disorders.

Competitive rivalry: The market is moderately competitive due to presence of global and regional players.

SWOT Analysis

Strength: High demand for lactulose syrup and tablets to treat constipation and hepatic encephalopathy. Established supply chain and distribution channels of key players.

Weakness: High capital requirements and stringent regulations delay entry of new players. Seasonal availability and price fluctuations of raw materials.

Opportunity: Rising geriatric population prone to constipation and liver disorders boost product demand. Emerging economies with growing healthcare expenditure present new opportunities.

Threats: Intense competition from substitutes like milk of magnesia, miralax and fiber supplements. Patent expiries of branded products allow entry of generics.

Key Takeaways

The Global Lactulose Market Demand is expected to witness high growth at a CAGR of 3.6% during the forecast period of 2023 to 2030. The market size is projected to reach US$ 175.29 Mn in 2023.

Regional analysis - North America dominates the global market and is expected to retain its leading position throughout the forecast period owing to rising healthcare spending and high adoption of lactulose products. The Asia Pacific market is projected to be the fastest growing region due to improving access to healthcare facilities, lifestyle changes and increasing prevalence of target diseases.

Key players - Key players operating in the lactulose market are Abbott, Morinaga Milk Industry CO., LTD., RELAX EXCELLENCE IN LACTULOSE, FRESENIUS KABI, BIOFAC A/S and Lactose India Limited. Abbott dominates the global market owing to its wide geographical presence and product offerings.

Get more insights on this topic:

https://www.rapidwebwire.com/lactulose-market-trends-size-and-share-analysis/